Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients

NCT01415674

Conditions
Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck, +6 more
Locations
  • CHU d'Angers Angers, France
  • Institut de cancérologie de l'Ouest - Site Paul Papin Angers, France
  • Centre François Baclesse Caen, France
  • Centre Léon Bérard Lyon, France
View Trial Details
Completed

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

NCT02001623

Conditions
Adnexal Diseases, Bladder Cancer, Carcinoma, +46 more
Locations
  • University of California Irvine Medical Center (UCIMC) Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • University Gynecologic Oncology Atlanta, Georgia, United States
View all 29 locations
View Trial Details
Completed

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

NCT01772004

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Cortex Diseases, +62 more
Locations
  • Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States
  • Scottsdale Healthcare Corporation Scottsdale, Arizona, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 74 locations
View Trial Details
Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details
Completed

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

NCT02636036

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +21 more
Locations
  • University of Arizona Cancer Center, 1515 North Campbell Ave. Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center, 1500 E Duarte Str. Duarte, California, United States
  • UCLA Medical Center, 10945 Le Conte Ave, Ste. 3360 Santa Monica, California, United States
  • Horizon Oncology Research, 1345 Unity Place, Suite 365 Lafayette, Indiana, United States
View Trial Details

Related conditions